In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor. Subscribe to our ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

FDA approves CBI-1214 for colorectal cancer, enabling fast-tracked clinical trials and highlighting innovative T-cell engager technology.

Polish scientists have developed and tested a chemical compound that shows strong activity against colorectal cancer cells ...

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

The study looked at blood samples from 30 overweight adults taken before and immediately after a max-effort cycling workout, which lasted about 10 to 12 minutes. They then exposed human colon cancer ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) ...